Aggressive Anti-TNF Rx in Moderate Crohn Disease and an Elevated CRP?

A new analysis supports a strategy of aggressive adalimumab treatment in moderately ill patients with Crohn disease who have a CRP of 10 mg/L or greater.
Source: Consultant Live - Category: Primary Care Source Type: news